AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...
Vous n'êtes pas connecté
WA’s first trial of psilocybin - from magic mushrooms - to help treatment-resistant depression is underway, with the first patient reporting good results. Where do we go from here?
AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...
Drug-resistant disease-causing microbes can infect any one of us. Bhakti Chavan, a promising biotechnologist, who never had TB before, got infected...
A device worn on the head, which emits a very low-frequency magnetic field, has improved symptoms in four male patients with major depressive...
71% of patients found to experience a relapse compared with 43% who received the pills twice a week
Below is a statement from the Queen Elizabeth Hospital The Accident and Emergency Department is currentlyexperiencing a significant increase in number...
Last year, Oregon became the first state to offer state-regulated access to supervised services involving magic mushrooms, specifically psilocybin....
More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...
THURSDAY, June 27, 2024 -- As psilocybin mushrooms become the most popular psychedelic in the United States, some states have started to ease...
WHO estimates that there are 39 million HIV patients living in the world with a death rate of around 630,000 per year. A figure that seems high but 20...
FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...